Mountain rescue team issues statement following death of walker
A Lake District mountain rescue team has expressed its sympathies to the family of a man who died whilst walking by Lodore Falls.
Keswick Mountain Rescue Team were called out to Gowder Crag on May 22 after a man collapsed while walking along the path.
Team members, alongside Great North Air Ambulance, Cumbria Police, and the North West Ambulance Service, provided medical response but were unable to save the walker.
A spokesperson for Keswick MRT said: "Members of a walking group were out enjoying the amazing weather on a beautiful walk up the side of Lodore Falls when one of them collapsed on the path.
"Members of the group immediately commenced CPR whilst they called for help.
"On arrival the team, alongside ambulance paramedics, GNAAS and Police medical response did what they could but unfortunately were unable to save the man.
"Our deepest thoughts and sympathies go out to the family and friends of the man."
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Hornets players invite fans to sign up for special stair climb
Watford players are inviting people to join a special stair climbing event and help make a difference in the community. Vicarage Road Stadium will host the Step Up Challenge on July 5, coinciding with the 77th birthday of the NHS. Defenders James Morris and James Clarridge and midfielders Anna Filbey and Leo Ramirez-Espain are encouraging fans to participate. The event, open to football lovers, fitness aficionados, and families, will see participants walking, running, or climbing through the 20,000-plus seat stadium. The money raised will go towards enhancing the health and wellbeing of thousands of local residents through Watford FC's Community Sports and Education Trust and West Herts Hospitals Charity. The Step Up Challenge will take place on July 5, which coincides with the 77th birthday of the NHS. (Image: Watford FC Trust) Anna, who is ambassador for West Herts Hospitals Charity, said: "We're excited to invite fans to take part in the Step Up Challenge at Vicarage Road. "It's a fantastic way to support our local NHS hospitals and Watford FC's Community Trust, while celebrating 77 years of the NHS's incredible service." The funds generated will aid West Herts Hospitals Charity in its mission to enhance patient care and staff welfare across at Watford General, Hemel Hempstead and St Albans City hospitals. The charity recently funded a new 'Wellbeing Courtyard' at Watford General, providing patients with access to fresh air and a peaceful retreat for NHS staff to recharge. The Step Up Challenge is suitable for all, offering both a full and half route. The event is suitable for all, offering a full and half route. (Image: Watford FC Trust) There is a £15 registration fee for adults (18 years and over) and a £5 fee for young people (6–18 years). To join the challenge at Vicarage Road Stadium on Saturday, July 5, visit the registration link via The event is not only an opportunity for participants to challenge themselves but also a chance to contribute towards a vital cause, supporting healthcare in the local community. Whether you're a fitness enthusiast looking to set a new personal record or someone wanting to enjoy a unique challenge while supporting healthcare, the Step Up Challenge is an initiative that combines fitness, fun, and philanthropy. Join Watford FC players in this one-of-a-kind event and make a difference in the community.
Forbes
an hour ago
- Forbes
Meet Dirtea And The Brothers Brewing The Functional Mushroom Revolution
Dirtea founders and brothers Simon (L) and Andrew (R) Salter Super-successful serial entrepreneurs, brothers Simon and Andrew Salter – Andrew was a member of the Forbes 30 under 30 class of 2020 for the work of their Limelyte culture and innovation studio; unfortunately, older brother Simon aged out– suffered from a malady common to those in their profession: burnout. Looking for a safe, effective and natural solution, they discovered that functional mushrooms delivered the health and wellbeing benefits they were searching for. And being serial entrepreneurs, they were wired to bring their discovery to the world through a new venture – Dirtea – their first product-centric business. 'We started Dirtea because nothing we tried fixed the burnout issue, not coffee, not supplements, none of the wellness fads. Once we found mushrooms, we couldn't find a brand that we trusted or that spoke our language. So we built Dirtea to be trusted, to be potent, efficacious and the best functional mushroom products in the world in terms of quality,' Andrew explained. London-based Dirtea launched in 2016 and has made a big splash across the pond with its range of mushroom-infused coffee, matcha, chai and cacao blends, as well as powder supplements and gummies. Dirtea is carried in nearly 2,000 stores in the U.K., including Selfridge, Harrods, Boots, Planet Organic and SoulCycle and is offered in numerous coffee shops. A notable example is the Dirtea 'Feel Good Bar' in Selfridges London, which started as a pop-up but earned the right to become a full-time concession. While Dirtea is available to U.S. consumers via its website and Amazon, it's readying to launch the 'Shroom Boom' on this side of the pond. Starting this fall, Dirtea gummies will be featured in 750 Vitamin Shoppe stores nationwide. Physical stores serve a dual purpose. They are a platform to educate consumers about the health benefits of functional mushrooms and are a central hub to foster the Dirtea community, leveraging their experience launching the #FeelingNuts campaign against testicular cancer that went viral and the digital-concierge service Velocity Black, which was acquired by Capital One in 2023. For thousands of years, functional mushrooms have been used in traditional Chinese and India's Ayurveda medicine, but only recently has science caught up with the healing power of mushrooms. The number of scientific papers published on functional mushrooms has exploded since the turn of the century, according to the National Library of Medicine's database. In 2000, it catalogued 230 papers. In 2024, there were more than 1,100 papers recorded. All that scientific work proving the effectiveness of mushrooms to boost immunity, enhance cognitive function, reduce stress and give an energy boost has crossed over into the mainstream. Fortune Business Insights estimates the global functional mushroom market reached $31 billion in 2024, will grow to nearly $34 billion this year and top $60 billion by 2032 at a compound-annual-growth rate of 9%. However, it could grow faster if the brothers are as successful as past history suggests. In 2014, the brothers launched the #FeelingNuts campaign to educate men about the early warning signs of testicular cancer that went viral with a billion people, including numerous high-profile celebrities, behind it and that was spun off as a British television special. Dirtea offers the power-five functional mushrooms each targeting specific wellness and health benefits: And each Dirtea formula is fortified with a nutritional supplement to give an extra kick. For example, Chaga, Cordyceps and Reishi products come with vitamin B12 and Lion's Mane and Tremella delivers a dose of zinc. Dirtea's chief science officer, Dr. Tara Swart, renown neuroscientist who holds both an M.D. and a Ph.D., assures all products meet the highest clinical standards and guides development of new products. Beyond packing a health and wellbeing punch for consumers, the brothers know people have to experience the benefits to become Dirtea converts. That's where the Selfrigdes' Feel Good Bar and broadening distribution through branded experiences comes in. 'In business, we're known for building social movements and campaigns around consumer brands and causes as well,' Andrew said, adding, 'We've always leveraged entertainment and culture because we think that's the best way to build cult like followings.' For example, they just launched the first wellness nightclub pop-up experience in London, called the Dirtea Reset Club, that blends, education, sauna, music, culture into a healthy nightclub experience. 'We're giving people a chance to experience real dopamine so you wake up the next day feeling good, even better that before, not the fake kind you get spending time in a regular nightclub where you feel awful the morning after,' Simon shared. They have plans to take the Dirtea Reset Club on the road in New York and Los Angeles, 'It's a way to bring together a community,' Andrew said, noting that bringing people together into the Dirtea community is an essential part of the company's mission. Simon cites a study, also referenced in the 2023 U.S. Surgeon General's report 'Our Epidemic of Loneliness and Isolation,' that found loneliness and social isolation can have the same negative health effects as smoking up to 15 cigarettes a day, and its mortality impact is even greater than that associated with obesity and physical inactivity. 'Building community is our North Star and we want to give back to our community as much as they are giving to us as subscribers,' Simon continued. Dirtea thrives on its subscription business – what it calls the Dirtea Tribe. And to keep it building, the goal is to be more than just a wellness brand, but to make Dirtea a part of an individual's daily wellness ritual. 'Were not trying to be a wellness brand or a supplement. We're building a next generation of daily rituals that are powered by mushrooms, backed by science and designed for a culture running on empty,' Andrew explained. 'The reason why a brand like Dirtea can exist today is because everyone is running on empty. We've normalized burnout. We wake up with caffeine. We wind down with wine. We sleep with pills. It's a vicious cycle.' They see Dirtea as the way to break that vicious cycle and turn it into a virtuous circle for health and wellbeing. 'We're not here to biohack you. We're here to help you feel more like your best self,' he continued. Dirtea is backed by some heavy hitters. Roxie Nafousi, self-development coach and author of the best-selling Manifest: 7 Steps to Building Your Best Life, is an investor and brand ambassador, as is famed adventurer and television personality Bear Grylss. Grylss is an outspoken Christian, so I believe him when he says: 'I was a total convert. I had never felt that focus. I can genuinely hand on heart say that over the last year I've never felt so alive, so focused, happy and calm. But above all, I love what we stand for, bringing good health and natural healing to the masses.' Plus, Dirtea has partnerships with Stella McCartney, Barry's Bootcamp and Atis cosmetics brand, and the brothers have Benedict Cumberbatch, Idris Elba and Charlotte Tilbury, to name a few, on speed dial. 'We spent our careers building cultural moments and movements,' Andrew said, and the brothers brought that expertise to Dirtea. 'We're one of the leading wellness brands in the U.K. We've built a huge brand here now we're expanding globally and the U.S. market is, without a doubt, the biggest opportunity for us. 'Now with Vitamin Shoppe as our launch partner, we are ready to build the Dirtea movement online digitally and direct-to-consumer and soon we'll be the hallmark mushroom brand at Vitamin Shoppe,' he concluded.
Yahoo
an hour ago
- Yahoo
CN Bio introduces cross-species DILI services to enhance in vitro to in vivo extrapolation during preclinical drug development
Extends capabilities of industry-leading PhysioMimix DILI assay for comparative studies between animal species and human Generates deeper insights into inter-species differences to de-risk development pipelines and minimize animal testing CAMBRIDGE, England, June 10, 2025--(BUSINESS WIRE)--CN Bio, a leading provider of Organ-on-a-chip (OOC) systems and solutions that accelerate drug discovery and development workflows, has introduced two new animal microphysiological system (MPS) models that enhance translatability in preclinical drug safety and toxicology assessments to its Contract Research Services (CRS). Building upon the Company's FDA-recognized drug induced liver injury (DILI) assay, the expanded offering enables rapid, comparative studies between commonly used animal and human models to flag interspecies differences early, and better informs in vivo study design. Traditional human in vitro methods have limited capacity to accurately determine drug toxicity. Added to this, the discrepancies between these methods and in vivo animal studies make it challenging to accurately predict safety risks for humans during preclinical testing. Often, unsafe drug candidates are wrongly progressed, and potentially life-saving ones are misclassified and abandoned, ultimately impacting clinical progression. In response to growing market demand for tools that address these concerns, CN Bio has expanded the in vitro to in vivo extrapolation (IVIVE) capabilities of its established PhysioMimix® DILI assay, adding the ability to easily compare results across human-, rat-, and dog-derived Liver-on-a-chip models. These assays offer a modernized workflow to generate predictive and actionable insights that mitigate the risk of costly, late-stage conflicting data, and reduce unnecessary animal use by providing early warning of hepatotoxicity/DILI prior to in vivo studies. Accessible through the Company's CRS, the new offering harnesses the longstanding expertise of CN Bio's scientific team to provide detailed data analysis, optimized outcomes, and data-driven conclusions beyond what is achievable using existing in vitro models. The assay enables a broad range of longitudinal and endpoint testing for DILI-specific biomarkers from single- or repeat-dosing studies over a 14-day experimental window. This provides a more comprehensive overview of underlying mechanisms of hepatotoxicity or latent effects of drug candidates to improve IVIVE assessment and streamline clinical progression. Dr Emily Richardson, Lead Scientist, Safety and Toxicology, CN Bio, said: "Understanding safety risks is critical to successful drug development, however, fundamental physiological and biological differences between species can lead to inaccuracies in predictions, often causing drug candidates to be wrongfully abandoned as toxic, or worse, mistakenly classified as safe." She added: "Having established our DILI assay as an industry leading option to garner more valuable insights across the development pipeline, we were in an ideal position to expand its capabilities and address this crucial gap in understanding hepatotoxicity using the most commonly used animal models. Partnering with us to utilize this powerful service not only ensures robust and reliable results but also provides access to a team of Organ-on-a-chip experts, who are invested in your success; to de-risk your pipeline and move it forward with confidence." View source version on Contacts Media contact Lily JefferyTel: +44(0)7891477378Email: Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
